Coronavirus
In the context of supply issues, the African Union has abandoned plans to procure coronavirus vaccines from the Serum Institute in India and is now discussing possibilities with the U.S. Johnson & Johnson.
John Nkengasong, head of the African Disease Control Centers, said the sufficient supply of vaccine was crucial – and that export constraints by India is problematic for Africa.
He went on to say that the AU's decision had nothing to do with the potential connection to blood clots in some rare cases surrounding the Oxford-AstraZeneca vaccine.
He stressed that the AstraZeneca vaccine will still be distributed to Africa through the UN's Covax program.
Nkengasong claimed that the AU had already signed a contract with Johnson & Johnson for up to 400 million single dose vaccines.
11:15
Is time running out for Africa to industrialize? [Business Africa]
Go to video
New Zimbabwean president in Pan-African Parliament
Go to video
AU urges restraint over 'escalating' Ethiopia-Sudan tensions
Go to video
Morocco: AU and UN call for investigation into Melilla tragedy
02:47
African fashion and food celebrated at the African pop up festival in Brooklyn
01:50
More Israeli tourists are choosing to holiday in Sinai